GLENN PIERCE

Insider Reports History

Signature
/s/ Robin Swartz, as Attorney-in-Fact for Glenn Pierce
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by GLENN PIERCE:

Company Role Class Num Shares Value Price $ Report Date Ownership
Voyager Therapeutics, Inc. Director Stock Option (Right to Buy) 24,000 03 Jun 2025 Direct
Global Blood Therapeutics, Inc. Director Common Stock 0 $46.99 05 Oct 2022 Direct
Global Blood Therapeutics, Inc. Director Restricted Stock Units 0 05 Oct 2022 Direct
Global Blood Therapeutics, Inc. Director Stock Option (Right to Buy) 0 05 Oct 2022 Direct

Insider Reports Filed by GLENN PIERCE

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VYGR Voyager Therapeutics, Inc. 03 Jun 2025 1 $0 4 Director 04 Jun 2025, 21:07
VYGR Voyager Therapeutics, Inc. 05 Jun 2024 1 $0 4 Director 07 Jun 2024, 16:20
VYGR Voyager Therapeutics, Inc. 06 Jun 2023 1 $0 4 Director 07 Jun 2023, 16:41
/report/000089924322033156-pierce-glenn-2022-10-05 Global Blood Therapeutics, Inc. 05 Oct 2022 10 $0 4 Director 06 Oct 2022, 16:20
VYGR Voyager Therapeutics, Inc. 14 Jul 2022 1 -$63,730 4 Director 18 Jul 2022, 17:34
/report/000089924322022892-pierce-glenn-2022-06-14 Global Blood Therapeutics, Inc. 14 Jun 2022 4 $0 4 Director 16 Jun 2022, 18:01
VYGR Voyager Therapeutics, Inc. 06 Jun 2022 1 $0 4 Director 08 Jun 2022, 16:35
VYGR Voyager Therapeutics, Inc. 13 Jan 2022 2 $0 4 Interim CSO, Director 18 Jan 2022, 19:05
/report/000089924321024979-pierce-glenn-2021-06-17 Global Blood Therapeutics, Inc. 17 Jun 2021 4 $0 4 Director 21 Jun 2021, 16:24
VYGR Voyager Therapeutics, Inc. 07 Jun 2021 1 $0 4 Interim CSO, Director 08 Jun 2021, 16:09
VYGR Voyager Therapeutics, Inc. 03 Jun 2021 1 $0 4 Interim CSO, Director 04 Jun 2021, 16:31